Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Zeitschrift Fur Gastroenterologie|January 6, 2017
[Biosimilars in Inflammatory Bowel Disease (IBD): Experiences and perceptions of german gastroenterologists]Bernd Bokemeyer, Axel Dignaß, Stefan Schreiber
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 27, 2023
Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel diseaseIsa Maria Steiner, Bernd Bokemeyer, Tom Stargardt
Journal of Clinical Medicine|October 29, 2025
Real-World Effectiveness of Golimumab in Ulcerative Colitis: A Pooled Analysis from the Prospective UMBRELLA-IBD Registry in GermanyArne Bokemeyer, Thomas Wenske, Sandra Plachta-Danielzik, et al.
Inflammatory Bowel Diseases|February 8, 2022
Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims DataBernd Bokemeyer, Nils Picker, Thomas Wilke, et al.
Die Rehabilitation|November 5, 2020
[Work-Related Problems and Requested Support in Inflammatory Bowel Disease - Results of a Multi-Perspective Survey]Jana Langbrandtner, Gero Steimann, Christoph Reichel, et al.
Inflammatory Bowel Diseases|May 14, 2021
Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority TrialStefanie Howaldt, Eugeni Domènech, Nicholas Martinez, et al.
Die Rehabilitation|September 20, 2021
[Inflammatory Bowel Disease - Challenges in the Workplace and Support for Coping with Disease]Jana Langbrandtner, Gero Steimann, Christoph Reichel, et al.
International Journal of Colorectal Disease|May 7, 2023
Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in GermanyBernd Bokemeyer, Nils Picker, Daniel Kromer, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healingBernd Bokemeyer, Daan Hommes, Ivo Gill, et al.
Zeitschrift Fur Gastroenterologie|May 10, 2018
Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative ColitisAngelika Hüppe, Jana Langbrandtner, Winfried Häuser, et al.
Pageof 8